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Abstract:  Chronic hyperglycemia during diabetes leads to increased 
production of reactive oxygen species (ROS) and increased oxidative stress 
(OS). Here we investigated whether changes in the metabolic state can be 
used as a marker of OS progression in kidneys. We examined redox states 
of kidneys from diabetic mice, Akita
/+ and Akita
/+;TSP1
–/– mice (Akita mice 
lacking thrombospondin-1, TSP1) with increasing duration of diabetes. OS 
as measured by mitochondrial redox ratio (NADH/FAD) was detectable 
shortly after the onset of diabetes and further increased with the duration of 
diabetes. Thus, cryo fluorescence redox imaging was used as a quantitative 
marker of OS progression in kidneys from diabetic mice and demonstrated 
that alterations in the oxidative state of kidneys occur during the early 
stages of diabetes. 
© 2012 Optical Society of America 
OCIS codes: (260.2510) Fluorescence; (000.1430) Biology and medicine; (170.0110) Imaging 
systems; (170.3880) Medical and biological imaging; (170.6280) Spectroscopy, fluorescence 
and luminescence; (100.2960) Image analysis. 
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1. Introduction 
Diabetic nephropathy cases, which have doubled  in the past decade, account for 
approximately half of all end-stage renal disease cases [1–5]. Although oxygen is a necessary 
component for complex organisms that demand high energy, overproduction of reactive 
oxygen species (ROS) may cause DNA damage, cell death, and protein modifications that 
result in mitochondrial and cellular dysfunction [3,6–8]. Diabetes, a common metabolic 
disorder, can trigger excess generation of ROS and plays an important role in increasing OS 
oxidative stress (OS) in various tissues, including the kidney. The increased OS during 
diabetes exacerbates the progression of disease and its associated complications such as renal 
vascular and proximal tubule dysfunction [1,2,4]. However, the temporal and spatial aspects 
of these changes and, more specifically, the time of onset of OS during diabetes remain 
unknown. 
The bcl-2 gene plays a central role in maintaining the mitochondrial oxidative 
homeostasis and its expression is protective during hyperglycemia-induced lipid peroxidation 
and advanced glycation end product modifications in endothelial cells [9]. Thus, its absence 
causes a more oxidized state in tissue and, as such, the mitochondria is more oxidized in 
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–/– mice as compared with their controls. In addition, bcl-2 is an anti-apoptotic protein 
whose expression decreases significantly during diabetes, and thus is of direct interest for this 
study. 
Akita
/+ mice develop type 1 diabetes as early as 4 weeks of age. Enzymatic and non-
enzymatic sources contribute to ROS observed in the diabetic kidneys, including advanced 
glycation, mitochondrial respiration chain deficiencies, and NAD(P)H oxidase. OS occurs 
due to the inability of cells to detoxify excess amounts of ROS or loss of the cellular anti-
oxidant defense [1,5,10–12]. Thus, the tissue metabolic state is an indicator of cellular oxygen 
consumption, and it can be extracted from fluorescence images [13,14]. 
Thrombospondin-1 (TSP1) is a potent endogenous inhibitor of angiogenesis, whose 
expression is dramatically down regulated during diabetes. Our hypothesis is that decreased 
production of TSP1 promotes the development and progression of diabetic nephropathy. The 
Akita
/+;TSP1
–/– mouse is a novel diabetes model developed in Dr. Sheibani’s lab that exhibits 
severe nephropathies with a relatively short duration of diabetes compared with the parental 
Akita
/+ mice. Thus, the mice that carry the Akita mutation and lack TSP1 (TSP1
–/–) serve as a 
model for severe diabetic nephropathy. Here we propose to determine the impact of the 
combination of these genetic modifications on the mitochondrial redox state associated with 
the onset and progression of diabetes. To verify that TSP1
–/–  genotype itself does not 
contribute to a more oxidized mitochondria, we compared TSP1
–/– mice with Akita
/+;TSP1
–/– 
mice. 
Fluorescence imaging provides specific information on tissue using intrinsic fluorophores 
or exogenous tagged proteins. Since some of the molecules in the cell have intrinsic 
fluorophores and are able to fluoresce when excited with the appropriate wavelength, a 
growing field of fluorescence microscopy techniques relies on autofluorescent fluorophores. 
Fluorescence-based techniques are widely used in biomedical applications as 
diagnostic/therapeutic tools for early detection of various diseases such as cancers or heart 
disease. Optical fluorescence techniques have the potential to diagnose tissue metabolic states 
in intact organs. These techniques are widely used in biomedical applications and have been 
shown to have a high sensitivity and specificity for discriminating between diseased and non-
diseased tissue [15–17]. 
Mitochondrial metabolic coenzymes NADH (Nicotinamide Adenine Dinucleotide), and 
Flavoprotein Adenine Dinocleotide (FADH2) are the primary electron carriers in oxidative 
phosphorylation. NADH and FAD (the oxidized form of FADH2) are autofluorescent and can 
be monitored without exogenous labels through the use of optical techniques. These 
coenzymes are beneficial in that NADH is primarily fluorescent in its reduced biochemical 
state, whereas FAD is only fluorescent in its oxidized form. Therefore, by imaging these two 
coenzymes, we can probe the oxidative state of the metabolism in tissue. The fluorescent 
signals of these intrinsic fluorophores have been used as indicators of tissue metabolism in 
injuries due to hypoxia, ischemia, and cell death [11,18,19]. In addition, by evaluating the 
ratio of these two coenzymes, some of the confounding factors in determining this oxidative 
state can be removed, such as absorbers, including hemoglobin and collagen, as well as 
scattering effects. Our studies have demonstrated that the normalized ratio of these 
fluorophores, (NADH/FAD), called the mitochondrial redox ratio (RR), acts as a novel 
marker of the mitochondrial redox and metabolic state of tissue ex vivo and in vivo. Although 
this ratio is not a direct measure of the concentrations of these fluorophores, the fluorescence 
intensity measured is a relative measure of their concentrations. To date, several groups have 
used optical fluorescence imaging to probe the biochemical and morphological characteristics 
of tissues [15,18,20,21]. Here we employed 3D cryo fluorescence redox imaging to delineate 
the temporal distribution of OS in kidneys from mice with different durations of diabetes. 
We have used fluorescent imaging of these two proteins to determine the mitochondrial 
oxidative state in mice with the above genotypes, resulting in a total of 6 categories of mice, 
as follows. First, bcl-2
–/– mice, which are more sensitive to OS and thus are expected to have 
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+/+ controls to verify the ability of the system to 
detect differences in OS. Next, Akita
/+ and their wild type (WT) controls were studied to 
determine whether a change in OS is correlated with the presence of diabetes. Similar to 
bcl-2
–/–, Akita
/+ mice are more susceptible to OS and are thus expected to have a lower RR. 
Finally, Akita
/+;TSP1
–/– mice were compared with their control, TSP1
–/–, in order to evaluate 
the severity of diabetic nephropathy in these mice using the mitochondrial oxidative state as a 
quantitative marker. It should be noted that the name of each group indicates the only 
modification to the mouse, and thus Akita
/+, Akita
/+;TSP1
–/–  and TSP1
–/–  are not bcl-2 
deficient. 
2. Materials and methods 
2.1. Tissue preparation 
Bcl-2 mice were maintained and screened as previously described [22]. Ins2Akita 
heterozygous (Akita
/+) male mice were obtained from Jackson Laboratories, where the colony 
is maintained by breeding C57BL/6J inbred females with Ins2Akita heterozygous males. 
Control animals were C57BL/6J male littermates. Only male mice were used in the 
experiments described below. All diabetic mice were left untreated. All procedures were 
approved by the Institutional Animal Care and Use Committee of the University of 
Wisconsin-Milwaukee. Genomic DNA was prepared from tail biopsies and the transgenic 
Akita
/+  mice were identified by PCR screening using the following primers: 5′-
TGCTGATGCCCTGGCC TGCT-3′  and 5′-TGG TCCCACATATGCACATG-3′. The 
amplified fragments were digested with FNU 4 HI, as recommended by Jackson Laboratories. 
To generate Akita
/+;TSP1
–/– mice, Akita
/+ male mice were bred with TSP1
–/– female mice. 
The resulting Akita
/+;TSP1
+/–  male mice were then bred with TSP1
–/–  female mice. 
Akita
/+;TSP1
–/– male mice were determined by screening and the colony was maintained by 
breeding the respective male mice with TSP1
–/– female mice. The litters were screened for 
Akita
/+ [23] and TSP1
–/– as previously described [24,25]. 
Here a total of 14 groups of mice (5 mice per group) were studied, as described above. 
The mice were sacrificed and their kidneys were harvested and frozen rapidly for low 
temperature cryoimaging. The kidneys were embedded in a black mounting medium and 
scanned by the cryoimager in 500 slices each 10 µm apart through the whole kidney. 
2.2. Cryoimager 
Figure 1 shows the schematic for the 3D cryoimager used in this study. The cryoimager is an 
automated image acquisition and analysis system consisting of software and hardware 
designed to acquire fluorescence images of tissue sections. A motor-driven microtome 
sequentially sections frozen tissue at the desired slice thickness while filtered light from a 
mercury arc lamp excites up to five distinct fluorophores in the exposed surface of the tissue 
block. The excitation light source is a 200W mercury arc lamp filtered at the excitation 
wavelength of NADH and FAD, The excitation band pass filters used for NADH is 350 nm 
(80 nm bandwidth, UV Pass Blacklite, HD Dichroic, Los Angeles, CA) and for FAD is 437 
nm (20 nm bandwidth, 440QV21, Omega Optical, Brattleboro, VT) and the emission filters 
for NADH is 460 nm (50 nm bandwidth, D460/50M, Chroma, Bellows Falls, VT) and for 
FAD is 537 nm (50 nm bandwidth, QMAX EM 510-560, Omega Optical, Brattleboro, VT). 
At each slice, a CCD camera records a fluorescence image of the tissue block in pixel 
dimensions of 10 µm × 10 µm to be later analyzed for fluorophore distribution. The 
microtome is housed in a freezer unit that maintains the sample at –80°C during sample 
slicing and image acquisition. The resolution in the z direction of microtome slices can be as 
small as 5 μm. For this study, we used a resolution of 10 μm in the z direction, which resulted 
in ~500 z-slices per kidney [21]. 
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A calibration method was designed to compensate for day-to-day variation of light intensity 
and non-uniformity of the illumination pattern. At the beginning of each experiment and 
before slicing the tissue, a uniform fluorescent flat plate was placed in the same position as 
tissue and imaged in all channels to acquire the illumination pattern. Since the fluorescence of 
the standard is in both the NADH and FAD channels, it also accounts for day-to-day light 
intensity and uniformity changes in all channels. All the images in each channel were then 
normalized by dividing each image to the flat plate image, captured in the same channel. 
 
Fig. 1. Schematic of cryoimager [26]. 
2.4. Data analysis 
FAD and NADH autofluorescence images (containing 500 slices per kidney) from each group 
of kidneys were processed using MATLAB (The MathWorks, Inc., Natick, MA). The 
composite images were created using all the image slices for each kidney, for both NADH 
and FAD signals. The ratio of NADH and FAD, known as the mitochondrial redox ratio [27], 
was calculated voxel by voxel, using Matlab, according to Eq. (1). 
  Redox Ratio RR NADH / FAD = =    (1) 
 
Fig. 2. Images of NADH, FAD and RR for one representative kidney (8 weeks, wild type). The 
top panel is the result of volume rendering of half of the kidney and the bottom panel is the 
max projection of the whole volume in the z-axis. 
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first row of Fig. 2. The 2D representation of each kidney was then calculated using the 
maximum intensities along the z axis of the RR 3D volume (max projection). 
In the maximum projection method, first a full 3D volume of images was obtained, 
including RR, and then the maximum projection on the volumetric data was performed and 
the histograms were plotted for this maximum projection. The maximum projection is used 
since the entirety of the anatomy has a significant contribution in this representation. A 
histogram of the max projection of RR values in each group was created, and the mean (or 
first moment) of this histogram was calculated according to Eq. (2). 
 
11
1
_ (, )
y x N N
ij xy
Mean Kidney Maxpro i j
NN = =
=
× ∑∑    (2) 
where Nx and Ny are the number of pixels in the x and y directions and the pixel size in x and 
y is 10μm and 10μm. The previously mentioned histograms were calculated for quantitative 
comparison between bcl-2, Akita
/+, and Akita
/+;TSP1
–/– mice and their appropriate controls. 
Statistical analysis was also carried out for each group of kidneys using a one-tailed student's 
t-test with P < 0.001 as the criterion for statistical significance. 
3. Results 
To ensure that cryo fluorescence redox imaging could effectively measure increased OS in 
kidney sections we initially examined the RR in kidney sections of wild type (bcl-2
+/+) and 
bcl-2-deficient (bcl-2
–/–) mice. Bcl-2 plays an essential role during kidney development and 
lack of bcl-2 enhances apoptosis affecting kidney development and growth. Bcl-2
–/– mice 
have a number of defects, including smaller size, and die by six weeks of age from polycystic 
kidney disease and renal failure. Perhaps more important, bcl-2 plays a central role in 
maintaining mitochondrial oxidative homeostasis [28] and its deficiency has a significant 
impact on kidney development and function [9]. In addition, bcl-2 expression is significantly 
decreased during diabetes [29]. We tested the cryo fluorescence imaging method on kidneys 
from 3 week-old bcl-2
+/+ and bcl-2
–/– mice. Figure 3 shows the max projected images of 
NADH, FAD, and RR in bcl-2
+/+ and bcl-2
–/– mice kidneys. The RR indicates a more reduced 
biochemical state in kidneys from bcl-2
+/+ mice with a mean value of 2.17 compared with a 
much smaller mean value of 0.96 in kidneys from bcl-2
–/– mice. Thus, kidney sections from 
bcl-2
–/– mice consistently demonstrated increased OS as expected, and are shown in Fig. 3 by 
a decreased RR (NADH/FAD), confirming the usefulness of this method for measuring OS. 
Akita
/+  mice develop diabetes by 4 weeks of age. We next prepared pseudo color 
representations of the maximum projection NADH, FAD and RR images and histograms of  
 
 
Fig. 3. Representative max projected images of NADH, FAD and RR and their histograms in 
kidneys from 3 week old bcl-2
+/+ and bcl-2
–/– mice. 
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/+, and 12 week-
old TSP1
–/– and Akita
/+;TSP1
–/– mice (Fig. 4). 
Figure 4 displays, from left to right, images of NADH, FAD, and RR, as well as the RR 
histogram, for one pair of representative kidneys indicated above. The images show a 
significant decrease in the mean RR of kidneys from 8 and 12 week-old diabetic mice 
compared with controls. The RR showed a visible decrease in kidneys from 8 week-old 
diabetic mice compared with controls, which becomes more significant in kidneys from 12 
week-old diabetic mice compared with controls. Thus, these results showed an increase in 
kidneys’ OS with a longer duration of diabetes. The max projected images of Akita
/+;TSP1
–/– 
and TSP1
–/– mice are shown in the last row of Fig. 4. The results presented in the histogram 
indicate that the mean RR of kidney from 12 week-old Akita
/+;TSP1
–/–  mice showed a   
 
 
Fig. 4. Representative max projected NADH, FAD and RR images and their related histograms 
for kidneys from Akita
/+ and Akita
/+;TSP1
–/– mice and their controls. 
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and severe diabetes complications. These results are consistent with our histological 
examination of kidneys from these mice, which show more severe diabetic nephropathy. 
Figure 5 displays a bar graph plot comparing the mean values of the histograms of max 
projected images of kidneys from Akita
/+ and Akita
/+;TSP1
–/– mice versus their appropriate 
control male littermates. Our results show decreased RR for all Akita
/+ mice compared with 
their non-diabetic control littermates. 
 
Fig. 5. Bar graph plot comparing the mean values of the histograms of max projected images 
from Akita
/+ and Akita
/+;TSP1
–/– mice kidneys and their respective controls. The results show a 
difference between kidneys from 8 and 12 week-old non-diabetic and diabetic Akita
/+ mice (*p 
<0.001). P values were obtained from a one-tailed student's t-test. 
4. Discussion and conclusion 
In this study, RR was used as a quantitative marker of OS in the kidney. We demonstrated the 
use of a fluorescence optical imaging technique to delineate temporal distribution of OS 
during diabetes. We initially confirmed the utility of the methodology in kidneys from bcl-2
–/– 
mice. Bcl-2 is a known modulator of mitochondrial OS and its absence is associated with 
increased OS state. The RR showed a significant decrease in kidneys from bcl-2
–/– mice as 
compared with their wild-type counterpart. The difference in mean values of the histograms 
in Fig. 3 suggests that OS shifts the metabolic levels of cells. The result of three groups of 
diabetic mice and their control littermates demonstrated different redox images and mean 
values in all three groups and also showed increased OS with the progression of diabetes. 
Thus, the significant difference in the mean RR of kidneys from diabetic mice compared with 
their appropriate controls indicates that the sensitivity of RR can be used as a marker of renal 
OS. Since in the presence of excessive ROS during diabetes mitochondrial coenzymes NADH 
and FADH2  accumulate in their oxidized forms (NAD and FAD), the mitochondrial RR 
showed a decrease as a result of OS, as shown in Fig. 5. In the absence of TSP1, diabetes-
related damage to the kidney occurred more rapidly, which translated to a further decrease in 
RR compared with its control littermate (TSP1
–/–; Fig. 5) and enhanced renal complications. 
The Akita
/+ phenotype (diabetic) is key to affecting RR levels. The strong decrease in the 
mean value of Akita
/+;TSP1
–/– as compared with its control, TSP1
–/–, combined with the fact 
that TSP1
–/– does not itself decrease the mean value, provides evidence in support of our 
hypothesis that the lack of TSP1 exacerbates the pathogenesis of diabetic nephropathy. 
Our results demonstrate the utility of cryoimaging for measuring kidney tissue 
mitochondrial redox state in different stages of OS with the progression of diabetes. The RR 
reveals differences in tissue NADH, FAD, and RR signals between diabetic mice and their 
control littermates. Furthermore, the studies presented here set the stage for future studies, 
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mice to follow the progression of diabetes and potentially monitor the efficacy of therapeutic 
regimens. 
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